Mitochondrial drug delivery and mitochondrial disease therapy – An approach to liposome-based delivery targeted to mitochondria

Mitochondrion - Tập 7 - Trang 63-71 - 2007
Yuma Yamada1, Hidetaka Akita1, Kentaro Kogure1, Hiroyuki Kamiya1, Hideyoshi Harashima1
1Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan

Tài liệu tham khảo

Asoh, 2000, The super anti-apoptotic factor Bcl-xFNK constructed by disturbing intramolecular polar interactions in rat Bcl-xL, J. Biol. Chem., 275, 37240, 10.1074/jbc.M005841200

Asoh, 2002, Protection against ischemic brain injury by protein therapeutics, Proc. Natl. Acad. Sci. USA, 99, 17107, 10.1073/pnas.262460299

Asoh, 2005, Zonal necrosis prevented by transduction of the artificial anti-death FNK protein, Cell Death Differ., 12, 384, 10.1038/sj.cdd.4401569

Chen, 2001, Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair, Biochem. Biophys. Res. Commun., 285, 188, 10.1006/bbrc.2001.5156

Chinnery, 2000, Mitochondrial DNA mutations in the pathogenesis of human disease, Mol. Med. Today, 6, 425, 10.1016/S1357-4310(00)01805-0

D’Souza, 2003, DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells, J. Control Release, 92, 189, 10.1016/S0168-3659(03)00297-9

D’Souza, 2005, Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria, Mitochondrion, 5, 352, 10.1016/j.mito.2005.07.001

Del Gaizo, 2003, A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta, Mol. Ther., 7, 720, 10.1016/S1525-0016(03)00130-8

Del Gaizo, 2003, Targeting proteins to mitochondria using TAT, Mol. Genet. Metab., 80, 170, 10.1016/j.ymgme.2003.08.017

Douglas, 1985, Nuclear genes encoding mitochondrial proteins in yeast, Trends Biochem. Sci., 10, 192, 10.1016/0968-0004(85)90189-6

Embury, 2001, Proteins linked to a protein transduction domain efficiently transduce pancreatic islets, Diabetes, 50, 1706, 10.2337/diabetes.50.8.1706

Endo, 1995, Avidin fusion protein as a tool to generate a stable translocation intermediate spanning the mitochondrial membranes, J. Biochem. (Tokyo), 118, 753, 10.1093/oxfordjournals.jbchem.a124976

Flierl, 2003, Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid, Mol. Ther., 7, 550, 10.1016/S1525-0016(03)00037-6

Futaki, 2002, Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms, Int. J. Pharm., 245, 1, 10.1016/S0378-5173(02)00337-X

Goto, 1990, A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies, Nature, 348, 651, 10.1038/348651a0

Green, 1998, Mitochondria and apoptosis, Science, 281, 1309, 10.1126/science.281.5381.1309

Gupta, 2005, Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides, Adv. Drug Deliv. Rev., 57, 637, 10.1016/j.addr.2004.10.007

Holt, 1988, Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies, Nature, 331, 717, 10.1038/331717a0

Holt, 1990, A new mitochondrial disease associated with mitochondrial DNA heteroplasmy, Am. J. Hum. Genet., 46, 428

Kagawa, 2001, Gene therapy by mitochondrial transfer, Adv. Drug Deliv. Rev., 49, 107, 10.1016/S0169-409X(01)00129-6

Kakudo, 2004, Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system, Biochemistry, 43, 5618, 10.1021/bi035802w

Kamiya, 2003, Pharmacokinetic and pharmacodynamic considerations in gene therapy, Drug Discov. Today, 8, 990, 10.1016/S1359-6446(03)02889-7

Khalil, 2006, Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery, Pharmacol. Rev., 58, 32, 10.1124/pr.58.1.8

Khalil, 2006, High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression, J. Biol. Chem., 281, 3544, 10.1074/jbc.M503202200

Kogure, 2004, Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method, J. Control Release, 98, 317, 10.1016/j.jconrel.2004.04.024

Mayer, 1995, Mitochondrial protein import: reversible binding of the presequence at the trans side of the outer membrane drives partial translocation and unfolding, Cell, 80, 127, 10.1016/0092-8674(95)90457-3

Moriguchi, 2005, A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids, Int. J. Pharm., 301, 277, 10.1016/j.ijpharm.2005.05.021

Muratovska, 2001, Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease, Nucl. Acid. Res, 29, 1852, 10.1093/nar/29.9.1852

Nakamura, 2006, Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide, J. Pharm. Pharmacol., 58, 431, 10.1211/jpp.58.4.0002

Newman, 1993, Leber’s hereditary optic neuropathy. New genetic considerations, Arch. Neurol., 50, 540, 10.1001/archneur.1993.00540050082021

Nishikawa, 1989, Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study, Neurology, 39, 399, 10.1212/WNL.39.3.399

Oku, 1994, Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice, Int. J. Cancer, 58, 415, 10.1002/ijc.2910580318

Otsuka, 1990, Marked decrease of mitochondrial DNA with multiple deletions in a patient with familial mitochondrial myopathy, Biochem. Biophys. Res. Commun., 167, 680, 10.1016/0006-291X(90)92079-F

Owen, 2000, Recombinant adeno-associated virus vector-based gene transfer for defects in oxidative metabolism, Hum. Gene Ther., 11, 2067, 10.1089/104303400750001381

Pfeiffer, 1995, The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition, J. Biol. Chem., 270, 4923, 10.1074/jbc.270.9.4923

Saraste, 1999, Oxidative phosphorylation at the fin de siecle, Science, 283, 1488, 10.1126/science.283.5407.1488

Schatz, 1996, The protein import system of mitochondria, J. Biol. Chem., 271, 31763, 10.1074/jbc.271.50.31763

Scheffler, 2000, A century of mitochondrial research: achievements and perspectives, Mitochondrion, 1, 3, 10.1016/S1567-7249(00)00002-7

Schwarze, 2000, Protein transduction: unrestricted delivery into all cells?, Trends Cell Biol., 10, 290, 10.1016/S0962-8924(00)01771-2

Seaton, 1992, Expression of human ferredoxin in Saccharomyces cerevisiae: mitochondrial import of the protein and assembly of the [2Fe-2S] center, Arch. Biochem. Biophys., 294, 603, 10.1016/0003-9861(92)90731-B

Seibel, 1995, Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases, Nucl. Acid. Res., 23, 10, 10.1093/nar/23.1.10

Shanske, 1990, Widespread tissue distribution of mitochondrial DNA deletions in Kearns–Sayre syndrome, Neurology, 40, 24, 10.1212/WNL.40.1.24

Shoffner, 1990, Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation, Cell, 61, 931, 10.1016/0092-8674(90)90059-N

Shokolenko, 2003, The expression of exonuclease III from E. coli in mitochondria of breast cancer cells diminishes mitochondrial DNA repair capacity and cell survival after oxidative stress, DNA Repair (Amst), 2, 471, 10.1016/S1568-7864(03)00019-3

Shokolenko, 2005, TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells, DNA Repair (Amst), 4, 511, 10.1016/j.dnarep.2004.11.009

Smith, 1999, Selective targeting of an antioxidant to mitochondria, Eur. J. Biochem., 263, 709, 10.1046/j.1432-1327.1999.00543.x

Srivastava, 2001, Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease, Hum. Mol. Genet., 10, 3093, 10.1093/hmg/10.26.3093

Suzuki, 1995, A case of diabetic amyotrophy associated with 3243 mitochondrial tRNA(leu; UUR) mutation and successful therapy with coenzyme Q10, Endocr. J., 42, 141, 10.1507/endocrj.42.141

Tanaka, 1997, Treatment of mitochondrial encephalomyopathy with a combination of cytochrome C and vitamins B1 and B2, Brain Dev., 19, 262, 10.1016/S0387-7604(97)00573-1

Tanaka, 2002, Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria, J. Biomed. Sci., 9, 534

Taniike, 1992, Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy, Biochem. Biophys. Res. Commun., 186, 47, 10.1016/S0006-291X(05)80773-9

Tranebjaerg, 1995, A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22, J. Med. Genet., 32, 257, 10.1136/jmg.32.4.257

Vestweber, 1989, DNA–protein conjugates can enter mitochondria via the protein import pathway, Nature, 338, 170, 10.1038/338170a0

Wadia, 2003, Modulation of cellular function by TAT mediated transduction of full length proteins, Curr. Protein Pept. Sci., 4, 97, 10.2174/1389203033487289

Wallace, 1999, Mitochondrial diseases in man and mouse, Science, 283, 1482, 10.1126/science.283.5407.1482

Wallace, 2005, A Mitochondrial paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine, Annu Rev Genet., 39, 359, 10.1146/annurev.genet.39.110304.095751

Wallace, 2005, The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement, Gene, 354, 169, 10.1016/j.gene.2005.05.001

Weissig, 2001, Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems, Adv. Drug Deliv. Rev., 49, 127, 10.1016/S0169-409X(01)00131-4

Weissig, 2001, DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria, J. Control Release, 75, 401, 10.1016/S0168-3659(01)00392-3

Weissig, 2004, Mitochondrial pharmaceutics, Mitochondrion, 3, 229, 10.1016/j.mito.2003.11.002

Yamada, 2005, Development of efficient packaging method of oligodeoxynucleotides by a condensed nano particle in lipid envelope structure, Biol. Pharm. Bull., 28, 1939, 10.1248/bpb.28.1939

Yamada, 2005, Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy, Int. J. Pharm., 303, 1, 10.1016/j.ijpharm.2005.06.009

Zhang, 1998, Photosensitisation properties of mitochondrially localised green fluorescent protein, Biochem. Biophys. Res. Commun., 242, 390, 10.1006/bbrc.1997.7970

Zimmerberg, 1986, Polymer inaccessible volume changes during opening and closing of a voltage-dependent ionic channel, Nature, 323, 36, 10.1038/323036a0

Thông tin
Thông tin xuất bản

Mitochondrion

Tập 7

63-71

Thông tin tác giả